Cargando…
The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia
BACKGROUND: Cyclooxygenase (COX)-2 inhibitors including celecoxib are as effective as non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs) in the treatment of osteoarthritis (OA) and have less gastrointestinal toxicity. Although they are associated with higher treatment costs, COX-2 inhib...
Autores principales: | Nasef, Sherif A, Shaaban, A. Aziz, Mould-Quevedo, Joaquin, Ismail, Tarek A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467807/ https://www.ncbi.nlm.nih.gov/pubmed/26061682 http://dx.doi.org/10.1186/s13561-015-0053-7 |
Ejemplares similares
-
The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria
por: Hammoumraoui, Nadir, et al.
Publicado: (2013) -
Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in Saudi Arabia
por: Aljahdli, Emad S, et al.
Publicado: (2022) -
The Pattern of Intravenous Proton-Pump Inhibitor Utilization at an Academic Medical Center in Riyadh, Saudi Arabia
por: Mohzari, Yahya Ali, et al.
Publicado: (2020) -
Public Knowledge of Osteoarthritis in Al-Qunfudah Governorate, Saudi Arabia
por: Alkalash, Safa H, et al.
Publicado: (2023) -
Assessment of Awareness and Knowledge of Proton Pump Inhibitors Among the General Population in the Qassim Region, Saudi Arabia
por: Almuzaini, Reema, et al.
Publicado: (2023)